ACG Wealth’s GALENA BIOPHARMA INC COM RXII Stock Holding History

ACG Wealth’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,000	Closed	-$9K	–	282
2016 Q3	$9K	Hold	25,000	–	–	﹤0.01%	248
2016 Q2	$12K	Buy	+25,000	New	+$12K	﹤0.01%	218

ACG Wealth's RXII Position: Q4 2016 in Review

ACG Wealth sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 25,000 shares — an estimated $9K sold.

ACG Wealth first reported a position in RXII in Q2 2016 and held it in 2 quarters. The position peaked at $12K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

ACG Wealth reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
ACG Wealth sold 25,000 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $9K.
ACG Wealth first reported a position in GALENA BIOPHARMA INC COM in Q2 2016 and held it in 2 quarters.
ACG Wealth's GALENA BIOPHARMA INC COM position peaked at $12K in Q2 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on ACG Wealth's 13F filing for Q4 2016, filed 8 Feb 2017.